Sep 11, 2026 07:24AM
Jul 28, 2026 01:38PM
Jul 28, 2026 07:00AM
Jul 13, 2026 04:00AM
Jul 13, 2026 04:00AM
Jul 6, 2026 08:39AM
Jul 6, 2026 08:39AM Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio
Jun 26, 2026 09:00AM
Jun 26, 2026 09:00AM
Jun 10, 2026 07:11AM
Jun 9, 2026 09:11AM
Jun 8, 2026 02:49PM
Jun 8, 2026 07:00AM
Jun 8, 2026 07:00AM Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders
Jun 2, 2026 04:37AM
May 6, 2026 04:30PM
Apr 28, 2026 07:00AM
Feb 10, 2026 07:00AM
Dec 3, 2025 04:30PM
Nov 4, 2025 07:01AM
Nov 4, 2025 07:01AM Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
Oct 28, 2025 07:00AM
Sep 24, 2025 04:30PM
Sep 18, 2025 04:15AM
Aug 27, 2025 04:15PM
Aug 25, 2025 08:00AM
Aug 25, 2025 08:00AM
Jul 29, 2025 07:00AM Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Jul 2, 2025 04:30PM
Jun 26, 2025 12:27PM
Jun 26, 2025 10:36AM
Jun 26, 2025 09:18AM
Jun 26, 2025 07:30AM
Jun 26, 2025 07:30AM
Apr 29, 2025 07:00AM Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Feb 10, 2025 07:00AM
Oct 30, 2024 05:47AM
Oct 29, 2024 07:00AM
Aug 19, 2024 05:58AM
Jul 30, 2024 07:03AM
Jul 30, 2024 07:00AM
Jul 2, 2024 04:15AM BMO Capital Downgrades Incyte (INCY) to Underperform
May 30, 2024 04:05PM
May 21, 2024 01:16PM
May 21, 2024 01:15PM
May 1, 2024 06:30AM
Apr 30, 2024 03:17PM
Apr 30, 2024 07:00AM
Apr 24, 2024 08:18AM BMO Capital Reiterates Market Perform Rating on Incyte (INCY)
Apr 24, 2024 07:20AM

1,199,224 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All